|Articles|April 1, 2011
- Pharmaceutical Executive-04-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - April 2011
A Silver Lining
Advertisement
Articles in this issue
over 14 years ago
iLogisticaover 14 years ago
Off-Label But On Point?over 14 years ago
Pharm Exec Wins a Neal Award!over 14 years ago
Espacio Riescoover 14 years ago
Restoring Public Trust in Pharmaover 14 years ago
HBA Woman of the Year: Freda Lewis-Hallover 14 years ago
Revisiting ReformNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
ACS Calls Obesity a Condition That Must Be Treated with Medication and Surgery
5
